ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
120 hedge funds and large institutions have $181M invested in Antares Pharma, Inc. in 2018 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 37 increasing their positions, 33 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8% less capital invested
Capital invested by funds: $197M → $181M (-$16.6M)
58% less call options, than puts
Call options by funds: $632K | Put options by funds: $1.49M
Holders
120
Holding in Top 10
3
Calls
$632K
Puts
$1.49M
Top Buyers
| 1 | +$3.21M | |
| 2 | +$2.82M | |
| 3 | +$2.22M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.54M |
| 5 |
FI
Fosun International
Hong Kong,
China
|
+$1.41M |
Top Sellers
| 1 | -$3.21M | |
| 2 | -$2.45M | |
| 3 | -$1.07M | |
| 4 |
MWP
MYCIO Wealth Partners
Philadelphia,
Pennsylvania
|
-$713K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$383K |